Thierry André Selected Research

Oxaliplatin (Eloxatin)

12/2021	Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin.
1/2021	Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials.
10/2020	Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.
2/2020	First-line trifluridine/tipiracil plus bevacizumab for unresectable metastatic colorectal cancer: SOLSTICE study design.
1/2020	"Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial".
1/2019	Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial.
1/2019	Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study.
1/2019	Phase I dose-escalation of trifluridine/tipiracil in combination with oxaliplatin in patients with metastatic colorectal cancer.
1/2018	Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.
1/2017	Observational Cohort Study of Patients With Metastatic Colorectal Cancer Initiating Chemotherapy in Combination With Bevacizumab (CONCERT).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thierry André Research Topics

Disease

97	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 09/2002
81	Neoplasms (Cancer) 04/2022 - 08/2002
47	Colonic Neoplasms (Colon Cancer) 02/2022 - 09/2002
25	Microsatellite Instability 04/2022 - 01/2004
20	Adenocarcinoma 06/2022 - 08/2002
12	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2002
11	Disease Progression 12/2020 - 03/2008
9	Pancreatic Neoplasms (Pancreatic Cancer) 03/2019 - 08/2002
9	Neutropenia 01/2019 - 01/2004
6	Turcot syndrome 06/2022 - 02/2019
6	Stomach Neoplasms (Stomach Cancer) 04/2020 - 01/2003
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 08/2017
5	Carcinoma (Carcinomatosis) 11/2020 - 01/2007
5	Hypertension (High Blood Pressure) 01/2019 - 12/2012
4	Sarcoma (Soft Tissue Sarcoma) 12/2020 - 03/2012
4	Asthenia 01/2019 - 01/2013
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 04/2022 - 07/2019
3	Fatigue 01/2020 - 01/2017
3	Nausea 01/2019 - 01/2004
3	Breast Neoplasms (Breast Cancer) 06/2015 - 08/2002
3	Lung Neoplasms (Lung Cancer) 01/2012 - 08/2002
2	Chromosomal Instability (Chromosome Stability) 04/2022 - 07/2016
2	Lymphatic Metastasis 02/2022 - 11/2021
2	Frailty 01/2022 - 08/2007
2	Neuroendocrine Carcinoma 01/2020 - 10/2016
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 07/2014
2	Vomiting 01/2019 - 01/2004
2	Diarrhea 01/2019 - 10/2013
2	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2017
2	Mucositis 01/2017 - 01/2004
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 09/2016 - 07/2014
2	Exanthema (Rash) 11/2015 - 10/2013
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 03/2014 - 09/2002
2	Alopecia (Baldness) 08/2004 - 01/2004
1	Extranodal Extension 11/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2021

Drug/Important Bio-Agent (IBA)

51	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 01/2003
48	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021 - 08/2002
35	Leucovorin (Folinic Acid)FDA Link 01/2020 - 01/2003
22	Immune Checkpoint InhibitorsIBA 04/2022 - 03/2016
22	Irinotecan (Camptosar)FDA LinkGeneric 02/2020 - 06/2003
20	Bevacizumab (Avastin)FDA Link 12/2020 - 07/2006
16	Biomarkers (Surrogate Marker)IBA 04/2022 - 05/2010
16	Cetuximab (Erbitux)FDA Link 12/2020 - 01/2005
13	ErbB Receptors (EGF Receptor)IBA 01/2021 - 05/2005
13	Gemcitabine FDA Link 11/2020 - 08/2002
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2007
11	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2003
11	Monoclonal AntibodiesIBA 01/2019 - 01/2007
8	Panitumumab (Vectibix)FDA Link 01/2021 - 11/2010
8	Capecitabine (Xeloda)FDA Link 07/2018 - 12/2006
7	Docetaxel (Taxotere)FDA Link 01/2022 - 08/2002
6	DNA (Deoxyribonucleic Acid)IBA 07/2019 - 01/2008
6	Pharmaceutical PreparationsIBA 01/2019 - 08/2002
5	Sodium Glutamate (Accent)IBA 01/2021 - 05/2008
5	regorafenibIBA 01/2021 - 05/2013
5	NivolumabIBA 11/2020 - 01/2017
5	Tyrosine Kinase InhibitorsIBA 01/2018 - 09/2002
5	PlatinumIBA 09/2016 - 08/2002
4	IpilimumabIBA 11/2020 - 10/2018
4	Calcibiotic Root Canal SealerIBA 01/2020 - 01/2017
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 01/2012
4	XELOXIBA 03/2016 - 12/2012
3	Circulating Tumor DNAIBA 10/2021 - 01/2020
3	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2018
3	trifluridine tipiracil drug combinationIBA 02/2020 - 07/2018
3	AntibodiesIBA 04/2019 - 01/2012
3	afliberceptIBA 01/2019 - 10/2013
3	130-nm albumin-bound paclitaxelIBA 01/2017 - 06/2015
3	Proteins (Proteins, Gene)FDA Link 07/2016 - 09/2012
2	tyramine-deoxysorbitolIBA 02/2022 - 11/2021
2	folfirinoxIBA 01/2021 - 01/2019
2	pembrolizumabIBA 12/2020 - 01/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 01/2018
2	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2017
2	dabrafenibIBA 01/2020 - 01/2018
2	trametinibIBA 01/2020 - 01/2018
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020 - 03/2012
2	Carcinoembryonic AntigenIBA 01/2019 - 01/2003
2	Epidermal Growth Factor (EGF)IBA 01/2018 - 05/2013
2	Trastuzumab (Herceptin)FDA Link 04/2015 - 04/2011
2	Epirubicin (Ellence)FDA LinkGeneric 11/2014 - 01/2006
2	Imatinib Mesylate (Gleevec)FDA Link 03/2014 - 09/2002
2	Phosphotransferases (Kinase)IBA 10/2013 - 09/2002
2	Angiogenesis InhibitorsIBA 07/2007 - 12/2006
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2004 - 05/2004
2	Hydroxyurea (Hydrea)FDA LinkGeneric 06/2003 - 01/2003
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	CTLA-4 AntigenIBA 01/2022
1	avelumabIBA 01/2021

Therapy/Procedure

58	Therapeutics 04/2022 - 09/2002
56	Drug Therapy (Chemotherapy) 04/2022 - 01/2004
27	Adjuvant Chemotherapy 02/2022 - 01/2004
9	Immunotherapy 07/2020 - 01/2017
4	Chemoradiotherapy 10/2016 - 01/2007
3	Neoadjuvant Therapy 06/2022 - 04/2017
2	Duration of Therapy 10/2021 - 01/2018
2	Aftercare (After-Treatment) 01/2017 - 01/2008
2	Induction Chemotherapy 05/2016 - 03/2008